Sunrun Inc vs Revolution Medicines Inc. Common Stock — how do they compare? Sunrun Inc trades at $7.54 (market cap $1.83B), while Revolution Medicines Inc. Common Stock trades at $191.04 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 22× Sunrun Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| RUN | RVMD | |
|---|---|---|
Market Cap | $1.83B | $40.32B |
Volume | 8,672,852 | 4,855,734 |
Sector | Energy | Health |
52-Week High | $21.41 | $221.15 |
52-Week Low | $7.59 | $47.50 |
Enterprise Value | $16.35B | $37.02B |
Typical Hold Time | — | 0 Days |
Signals from Pluang's Aura AI — not financial advice
Sunrun (RUN) trades at $7.58, down 0.39% on the day, reflecting a bearish technical trend. The stock shows attractive valuation ratios with a P/E of 5.16 and P/S of 0.59, while recent quarterly earnings have consistently beaten expectations. However, cash flow from operations remains negative, and the company faces headwinds from high borrowing costs impacting the solar sector. Positive developments include a record 580 MW grid dispatch with Tesla and expanded partnerships for distributed computing.
The outlook is mixed: strong analyst support with a $16.33 price target suggests significant upside, but operational cash burn and sector volatility pose risks. Investors should weigh low valuations against execution challenges and macroeconomic pressures affecting solar financing.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →